Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

7.60CAD
8:34pm BST
Change (% chg)

$0.02 (+0.26%)
Prev Close
$7.58
Open
$7.53
Day's High
$7.63
Day's Low
$7.48
Volume
9,440
Avg. Vol
35,225
52-wk High
$9.50
52-wk Low
$5.68

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 2.13
Market Cap(Mil.): $689.24
Shares Outstanding(Mil.): 83.54
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 85.33 32.76
EPS (TTM): -1.70 -- --
ROI: -60.83 2.22 14.61
ROE: -70.80 3.86 16.34

BRIEF-Aurinia Pharmaceuticals Reports Qtrly Loss Per Share ‍of $0.04​

* AURINIA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

15 Mar 2018

Earnings vs. Estimates